This is a series of front pages of articles of the various scientific publications where we have had, to date, tumors being developed by embryonic stem cells. These are in animal models because, of course, we do not have any human clinical trials that are taking place yet with embryonic stem cells. These are all in the animal field. But we are seeing continuously in the research results, as I stated earlier, that the embryonic stem cells injected into animal models are creating teratomas, creating tumors. This, as I quoted earlier, happened in the fetal tissue debate of 15 years ago, when they were creating teratomas or tumors, and we are now seeing the tumors come up again consistently in the research data on embryonic stem cell work. And here--this gets quite technical. But I wish to read some of the quotations in these various articles, that if any of my colleagues would like to look it up, this will be in the Record.
Sam Brownback: “This is a series of front pages of articles of the various scientific publications where we have had, to date, tumors…”
Editor's note · Context
Discussing the risks of embryonic stem cell research and its link to tumor development.
Share
More from Sam Brownback
I rise to speak in relation to the Comprehensive Iran Sanctions, Accountability and Divestment Act of 2010 and to congratulate my colleagues on its unanimous passage. This legislation is vital not only to sanction Iran for bad behavior but…
I wanted to engage my colleague from North Dakota because there is a strong base of bipartisan support to do this, and I also believe there is a strong majority community across America that supports this. Don't get it out there so wild…
I would continue the policies that have been done in the prior administration in working on these international issues.
I rise to discuss the nomination of Solicitor General Elena Kagan to the U.S. Supreme Court. Just over a year ago, the Senate considered the nomination of Judge Sonia Sotomayor to the Supreme Court and today we continue the debate on…





